Cravens & CO Advisors, LLC Abbott Laboratories Transaction History
Cravens & CO Advisors, LLC
- $135 Billion
- Q2 2024
A detailed history of Cravens & CO Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cravens & CO Advisors, LLC holds 9,680 shares of ABT stock, worth $1.11 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
9,680
Previous 7,253
33.46%
Holding current value
$1.11 Million
Previous $824 Million
22.01%
% of portfolio
0.75%
Previous 0.68%
Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,164Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.52 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.22 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.55 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...